Lymphomatoid papulosis: an update and review

Area of Science:

• Dermatology
• Oncology
• Pathology

Background:

• Lymphomatoid papulosis (LyP) is a chronic, relapsing CD30-positive cutaneous lymphoproliferative disorder.
• LyP presents with diverse morphologies and can overlap with primary cutaneous anaplastic cell lymphoma (pcALCL).
• Patients with LyP face an elevated risk of secondary malignancies.

Purpose of the Study:

• To review the clinical presentation, histopathological characteristics, and diagnostic challenges of LyP.
• To discuss the differential diagnosis of LyP, emphasizing its overlap with other CD30-positive disorders.
• To outline current management strategies for LyP.

Main Methods:

• Review of clinical and histopathological features of LyP.
• Analysis of diagnostic criteria and differential diagnoses.
• Summary of treatment and prognosis.

Main Results:

• LyP exhibits variable morphology and can mimic pcALCL, complicating diagnosis.
• Histological and immunophenotypic overlap with other CD30-positive disorders is common.
• Clinical correlation is essential for accurate LyP classification and prognosis.

Conclusions:

• Distinguishing LyP from pcALCL requires careful clinical and histological assessment.
• Early and accurate diagnosis of LyP is vital for appropriate patient management and risk stratification.
• Understanding the spectrum of LyP aids in predicting and managing associated neoplasms.